BBC Among Health Care ETFs
End-of-day Nov 11, 2026 · 39 Health care ETFs by Max
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.2% | +4.8% | +4.2% | −15.4% | +16.4% | +53.8% | +138.9% | −0.8% | +76.0% |
| Peer average | 0.0% | +2.0% | +6.5% | +5.2% | +23.3% | +33.2% | +72.4% | +28.6% | — |
| S&P 500 · VOO | −0.3% | −0.6% | −3.6% | −2.7% | +10.9% | +13.1% | +79.3% | +74.2% | — |
$23 of every $1,000 in BBC is Kodiak
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | KODKodiak Sciences | Healthcare | 2.33% | $232.70 | 6,859 | $735K |
| 2 | XNCRXencor | Healthcare | 2.32% | $231.55 | 19K | $731K |
| 3 | TRAXFirst Tracks Biotherapeutics | Healthcare | 2.08% | $208.46 | 13K | $658K |
| 4 | REPLReplimune Group | Healthcare | 1.85% | $185.47 | 26K | $585K |
| 5 | ABCLAbCellera Biologics | Healthcare | 1.76% | $176.50 | 45K | $557K |
| 6 | SGPSpyGlass Pharma | Healthcare | 1.54% | $153.95 | 13K | $486K |
| 7 | AMLXAmylyx Pharmaceuticals | Healthcare | 1.53% | $153.19 | 16K | $484K |
| 8 | VRDNViridian Therapeutics | Healthcare | 1.37% | $136.61 | 14K | $431K |
| 9 | KYMRKymera Therapeutics | Healthcare | 1.19% | $119.16 | 2,709 | $376K |
| 10 | PVLAPalvella Therapeutics | Healthcare | 1.18% | $118.28 | 2,145 | $373K |
| 11 | LBRXLB Pharmaceuticals | Healthcare | 1.17% | $117.46 | 8,218 | $371K |
| 12 | VIRVIR Biotechnology | Healthcare | 1.17% | $117.25 | 27K | $370K |
| 13 | PRMEPrime Medicine | Healthcare | 1.15% | $114.65 | 84K | $362K |
| 14 | MBXMBX Biosciences | Healthcare | 1.13% | $112.67 | 6,579 | $356K |
| 15 | MANEVeraDermics | Healthcare | 1.11% | $110.85 | 2,431 | $350K |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | KOD | Kodiak Sciences | 2.33% |
| 2 | XNCR | Xencor | 2.32% |
| 3 | TRAX | First Tracks Biotherapeutics | 2.08% |
| 4 | REPL | Replimune Group | 1.85% |
| 5 | ABCL | AbCellera Biologics | 1.76% |
| 6 | SGP | SpyGlass Pharma | 1.54% |
| 7 | AMLX | Amylyx Pharmaceuticals | 1.53% |
| 8 | VRDN | Viridian Therapeutics | 1.37% |
| 9 | KYMR | Kymera Therapeutics | 1.19% |
| 10 | PVLA | Palvella Therapeutics | 1.18% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $0.66 |
| Dec 20, 2024 | Dec 27, 2024 | $0.24 |
| Dec 20, 2023 | Dec 29, 2023 | $0.0823 |
| Dec 20, 2017 | Dec 27, 2017 | $0.30 |
| Dec 21, 2015 | Dec 29, 2015 | $0.15 |